SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4uy9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IIU_A_RTLA176_0 (PLASMA RETINOL-BINDING PROTEIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 11	ALA A 223 ALA A 169 MET A 220 LEU A 206 ARG A 303	None	1.23A	1iiuA-4uy9A: undetectable	1iiuA-4uy9A: 18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KT5_A_RTLA176_0 (PLASMA RETINOL-BINDING PROTEIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 12	ALA A 223 ALA A 169 MET A 220 LEU A 206 ARG A 303	None	1.28A	1kt5A-4uy9A: undetectable	1kt5A-4uy9A: 22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_A_ACTA860_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 6	GLY A 329 VAL A 320 ALA A 317 SER A 334	None	0.87A	1p6kA-4uy9A: undetectable	1p6kA-4uy9A: 22.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 6	ILE A 150 VAL A 158 ILE A 203 ILE A 264	None	0.64A	1uwhA-4uy9A: 27.2	1uwhA-4uy9A: 31.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XBB_A_STIA1_1 (TYROSINE-PROTEIN KINASE SYK)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 9	ALA A 169 ALA A 223 GLY A 226 PRO A 227 LEU A 275	None	0.57A	1xbbA-4uy9A: 20.7	1xbbA-4uy9A: 31.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	ALA A 169 GLY A 226 LEU A 275 THR A 293 ASP A 294 PHE A 295	None	0.57A	1xkkA-4uy9A: 27.6	1xkkA-4uy9A: 30.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 11	GLY A 151 GLY A 153 VAL A 158 ALA A 169 ALA A 223 LEU A 275 ASP A 294	None	0.74A	2evaA-4uy9A: 27.6	2evaA-4uy9A: 36.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_A_CHDA702_0 (FERROCHELATASE)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 7	LEU A 437 PRO A 318 MET A 316 TRP A 333	None	1.38A	2hrcA-4uy9A: undetectable	2hrcA-4uy9A: 20.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IVU_A_ZD6A3015_0 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	GLY A 151 VAL A 158 LYS A 171 LEU A 218 ALA A 223 LEU A 275 ASP A 294	None	0.87A	2ivuA-4uy9A: 26.2	2ivuA-4uy9A: 30.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD5_A_CHDA701_0 (FERROCHELATASE)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 8	LEU A 297 VAL A 209 GLY A 208 MET A 220	None	1.10A	2qd5A-4uy9A: undetectable	2qd5A-4uy9A: 19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD5_B_CHDB1103_0 (FERROCHELATASE)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 8	LEU A 297 VAL A 209 GLY A 208 MET A 220	None	1.07A	2qd5B-4uy9A: undetectable	2qd5B-4uy9A: 19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	ILE A 150 VAL A 158 ALA A 169 ILE A 204 GLY A 226 LEU A 275 ASP A 294	None	0.88A	2y7jA-4uy9A: 22.5	2y7jA-4uy9A: 23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 10	ILE A 150 VAL A 158 ALA A 169 ILE A 204 GLY A 226 LEU A 275 ASP A 294	None	1.02A	2y7jB-4uy9A: 22.8	2y7jB-4uy9A: 23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 10	ILE A 150 VAL A 158 ALA A 169 ILE A 204 GLY A 226 LEU A 275	None	0.73A	2y7jC-4uy9A: 22.3	2y7jC-4uy9A: 23.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 GLY A 226 LEU A 275 THR A 293 ASP A 294 PHE A 295	None	0.74A	3bbtB-4uy9A: 27.1	3bbtB-4uy9A: 33.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 GLY A 226 LEU A 275 THR A 293 ASP A 294 PHE A 295	None	0.69A	3bbtD-4uy9A: 27.4	3bbtD-4uy9A: 33.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 LEU A 218 GLY A 226 LEU A 275 THR A 293 PHE A 295	None	0.84A	3bbtD-4uy9A: 27.4	3bbtD-4uy9A: 33.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 LYS A 171 LEU A 218 GLY A 226 LEU A 275 THR A 293	None	1.23A	3bbtD-4uy9A: 27.4	3bbtD-4uy9A: 33.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 9	ILE A 150 ALA A 169 PHE A 222 LEU A 275 ASP A 294	None	0.65A	3ti1A-4uy9A: 22.9	3ti1A-4uy9A: 27.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	ALA A 169 LYS A 171 ILE A 204 LEU A 256 HIS A 266 ARG A 267 LEU A 275	None	0.78A	3zosB-4uy9A: 25.9	3zosB-4uy9A: 29.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AN2_A_EUIA1382_1 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	LEU A 218 ASP A 268 LYS A 270 ASN A 273 ASP A 294 GLY A 296	None	1.21A	4an2A-4uy9A: 25.8	4an2A-4uy9A: 27.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_B_CHDB503_0 (FERROCHELATASE, MITOCHONDRIAL)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 8	ILE A 352 PRO A 318 MET A 316 TRP A 333	None	1.26A	4f4dB-4uy9A: undetectable	4f4dB-4uy9A: 19.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 LYS A 171 GLY A 226 LEU A 275 THR A 293 ASP A 294	None	1.26A	4hjoA-4uy9A: 27.5	4hjoA-4uy9A: 31.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	VAL A 158 ALA A 169 ILE A 204 ASP A 268 LYS A 270 ASN A 273 LEU A 275	None	0.63A	4i41A-4uy9A: 20.7	4i41A-4uy9A: 27.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 12	GLY A 151 VAL A 158 ALA A 169 LEU A 206 LEU A 218 GLY A 226 LEU A 275	None	0.63A	4ifgA-4uy9A: 24.4	4ifgA-4uy9A: 24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M93_B_ACTB304_0 (S25-26 FAB (IGG1K) HEAVY CHAIN S25-26 FAB (IGG1K) LIGHT CHAIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 4	GLY A 329 SER A 330 ARG A 393 PRO A 390	None	1.43A	4m93B-4uy9A: 1.0 4m93C-4uy9A: 0.0	4m93B-4uy9A: 20.97 4m93C-4uy9A: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 11	GLY A 151 VAL A 158 ALA A 169 LYS A 171 ASN A 273 LEU A 275 ASP A 294	None	0.85A	4o0sA-4uy9A: 23.3	4o0sA-4uy9A: 27.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0U_A_ADNA501_1 (AURORA KINASE A)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 6	VAL A 158 ALA A 169 LYS A 171 LEU A 275	None	0.77A	4o0uA-4uy9A: 7.8	4o0uA-4uy9A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 8	ILE A 150 GLY A 153 VAL A 158 ALA A 169 ASN A 273 LEU A 275 ASP A 294	None	0.62A	4ogrA-4uy9A: 22.7	4ogrA-4uy9A: 26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 7	GLY A 151 ALA A 169 ASN A 273 LEU A 275 ASP A 294	None	0.86A	4ogrE-4uy9A: 21.8	4ogrE-4uy9A: 26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	7 / 9	ILE A 150 GLY A 153 VAL A 158 ALA A 169 ASN A 273 LEU A 275 ASP A 294	None	0.67A	4ogrI-4uy9A: 22.5	4ogrI-4uy9A: 26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	ILE A 150 GLY A 151 VAL A 158 ALA A 169 MET A 220 GLY A 226	None	0.80A	4qmzA-4uy9A: 23.9	4qmzA-4uy9A: 29.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	ILE A 150 GLY A 151 VAL A 158 ALA A 169 MET A 220 LEU A 275	None	0.64A	4qmzA-4uy9A: 23.9	4qmzA-4uy9A: 29.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 7	ILE A 204 ALA A 223 ARG A 267 ILE A 292	None	0.68A	4uxqA-4uy9A: 26.6	4uxqA-4uy9A: 31.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 7	VAL A 158 ILE A 204 ALA A 223 ILE A 292	None	0.49A	4uxqA-4uy9A: 26.6	4uxqA-4uy9A: 31.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 9	VAL A 158 LYS A 171 ILE A 204 ARG A 267 LEU A 275 ILE A 292	None	0.92A	4v01B-4uy9A: 26.9	4v01B-4uy9A: 31.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	VAL A 158 ALA A 169 ALA A 223 LEU A 256 HIS A 266 GLY A 296	None	0.72A	4v04A-4uy9A: 26.7	4v04A-4uy9A: 31.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 8	ILE A 204 ARG A 267 LEU A 275 ILE A 292	None	0.67A	4v04A-4uy9A: 26.7	4v04A-4uy9A: 31.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 12	ALA A 169 ALA A 223 LEU A 256 HIS A 266 GLY A 296	None	0.74A	4v04B-4uy9A: 26.7	4v04B-4uy9A: 31.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0R_A_PX9A201_0 (BETA-LACTOGLOBULIN)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 12	ILE A 249 LEU A 338 ILE A 274 ILE A 292 PHE A 396	None	0.86A	4y0rA-4uy9A: undetectable	4y0rA-4uy9A: 21.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HES_A_032A401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 12	VAL A 158 ALA A 169 ILE A 204 ALA A 223 PHE A 295	None	0.53A	5hesA-4uy9A: 32.8	5hesA-4uy9A: 40.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	GLY A 151 GLY A 153 VAL A 158 ALA A 169 LYS A 171 ASP A 294	None	0.98A	5hieC-4uy9A: 27.6	5hieC-4uy9A: 30.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JWA_H_ACTH612_0 (NADH DEHYDROGENASE, PUTATIVE)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	3 / 3	ARG A 393 PRO A 318 ASN A 364	None	1.06A	5jwaA-4uy9A: undetectable 5jwaH-4uy9A: undetectable	5jwaA-4uy9A: 20.12 5jwaH-4uy9A: 20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 9	ILE A 150 GLY A 151 VAL A 158 ALA A 169 ILE A 204	None	0.37A	5lw1B-4uy9A: 14.3	5lw1B-4uy9A: 14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MVM_A_PFLA510_1 (PROTON-GATED ION CHANNEL)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 9	ILE A 203 ALA A 205 ILE A 204 GLU A 221 ILE A 289	None	1.13A	5mvmA-4uy9A: undetectable 5mvmE-4uy9A: undetectable	5mvmA-4uy9A: 12.38 5mvmE-4uy9A: 12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	VAL A 158 ALA A 169 LYS A 171 LEU A 275 THR A 293 ASP A 294	None	1.25A	5yu9D-4uy9A: 27.0	5yu9D-4uy9A: 13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CNJ_A_NCTA402_1 (NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4 NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 7	CYH A 210 CYH A 217 TRP A 163 LEU A 144	None	1.48A	6cnjA-4uy9A: 0.0 6cnjB-4uy9A: 1.1	6cnjA-4uy9A: 13.44 6cnjB-4uy9A: 14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CNK_B_NCTB402_1 (NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4 NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2)	4uy9	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	4 / 7	CYH A 210 CYH A 217 TRP A 163 LEU A 144	None	1.48A	6cnkB-4uy9A: undetectable 6cnkC-4uy9A: undetectable	6cnkB-4uy9A: 13.44 6cnkC-4uy9A: 14.84

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1IIU_A_RTLA176_0","PLASMA RETINOL-BINDING PROTEIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ALA A 223;ALA A 169;MET A 220;LEU A 206;ARG A 303","None","1.23A","1iiuA-4uy9A:undetectable","1iiuA-4uy9A:18.94"],["1KT5_A_RTLA176_0","PLASMA RETINOL-BINDING PROTEIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ALA A 223;ALA A 169;MET A 220;LEU A 206;ARG A 303","None","1.28A","1kt5A-4uy9A:undetectable","1kt5A-4uy9A:22.98"],["1P6K_A_ACTA860_0","NITRIC-OXIDE SYNTHASE, BRAIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"GLY A 329;VAL A 320;ALA A 317;SER A 334","None","0.87A","1p6kA-4uy9A:undetectable","1p6kA-4uy9A:22.07"],["1UWH_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"ILE A 150;VAL A 158;ILE A 203;ILE A 264","None","0.64A","1uwhA-4uy9A:27.2","1uwhA-4uy9A:31.47"],["1XBB_A_STIA1_1","TYROSINE-PROTEIN KINASE SYK","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ALA A 169;ALA A 223;GLY A 226;PRO A 227;LEU A 275","None","0.57A","1xbbA-4uy9A:20.7","1xbbA-4uy9A:31.16"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"ALA A 169;GLY A 226;LEU A 275;THR A 293;ASP A 294;PHE A 295","None","0.57A","1xkkA-4uy9A:27.6","1xkkA-4uy9A:30.35"],["2EVA_A_ADNA498_1","TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"GLY A 151;GLY A 153;VAL A 158;ALA A 169;ALA A 223;LEU A 275;ASP A 294","None","0.74A","2evaA-4uy9A:27.6","2evaA-4uy9A:36.31"],["2HRC_A_CHDA702_0","FERROCHELATASE","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"LEU A 437;PRO A 318;MET A 316;TRP A 333","None","1.38A","2hrcA-4uy9A:undetectable","2hrcA-4uy9A:20.60"],["2IVU_A_ZD6A3015_0","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"GLY A 151;VAL A 158;LYS A 171;LEU A 218;ALA A 223;LEU A 275;ASP A 294","None","0.87A","2ivuA-4uy9A:26.2","2ivuA-4uy9A:30.95"],["2QD5_A_CHDA701_0","FERROCHELATASE","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"LEU A 297;VAL A 209;GLY A 208;MET A 220","None","1.10A","2qd5A-4uy9A:undetectable","2qd5A-4uy9A:19.62"],["2QD5_B_CHDB1103_0","FERROCHELATASE","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"LEU A 297;VAL A 209;GLY A 208;MET A 220","None","1.07A","2qd5B-4uy9A:undetectable","2qd5B-4uy9A:19.62"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"ILE A 150;VAL A 158;ALA A 169;ILE A 204;GLY A 226;LEU A 275;ASP A 294","None","0.88A","2y7jA-4uy9A:22.5","2y7jA-4uy9A:23.70"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"ILE A 150;VAL A 158;ALA A 169;ILE A 204;GLY A 226;LEU A 275;ASP A 294","None","1.02A","2y7jB-4uy9A:22.8","2y7jB-4uy9A:23.70"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"ILE A 150;VAL A 158;ALA A 169;ILE A 204;GLY A 226;LEU A 275","None","0.73A","2y7jC-4uy9A:22.3","2y7jC-4uy9A:23.70"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;GLY A 226;LEU A 275;THR A 293;ASP A 294;PHE A 295","None","0.74A","3bbtB-4uy9A:27.1","3bbtB-4uy9A:33.89"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;GLY A 226;LEU A 275;THR A 293;ASP A 294;PHE A 295","None","0.69A","3bbtD-4uy9A:27.4","3bbtD-4uy9A:33.89"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;LEU A 218;GLY A 226;LEU A 275;THR A 293;PHE A 295","None","0.84A","3bbtD-4uy9A:27.4","3bbtD-4uy9A:33.89"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;LYS A 171;LEU A 218;GLY A 226;LEU A 275;THR A 293","None","1.23A","3bbtD-4uy9A:27.4","3bbtD-4uy9A:33.89"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ILE A 150;ALA A 169;PHE A 222;LEU A 275;ASP A 294","None","0.65A","3ti1A-4uy9A:22.9","3ti1A-4uy9A:27.89"],["3ZOS_B_0LIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"ALA A 169;LYS A 171;ILE A 204;LEU A 256;HIS A 266;ARG A 267;LEU A 275","None","0.78A","3zosB-4uy9A:25.9","3zosB-4uy9A:29.26"],["4AN2_A_EUIA1382_1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"LEU A 218;ASP A 268;LYS A 270;ASN A 273;ASP A 294;GLY A 296","None","1.21A","4an2A-4uy9A:25.8","4an2A-4uy9A:27.33"],["4F4D_B_CHDB503_0","FERROCHELATASE, MITOCHONDRIAL","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"ILE A 352;PRO A 318;MET A 316;TRP A 333","None","1.26A","4f4dB-4uy9A:undetectable","4f4dB-4uy9A:19.62"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;LYS A 171;GLY A 226;LEU A 275;THR A 293;ASP A 294","None","1.26A","4hjoA-4uy9A:27.5","4hjoA-4uy9A:31.64"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"VAL A 158;ALA A 169;ILE A 204;ASP A 268;LYS A 270;ASN A 273;LEU A 275","None","0.63A","4i41A-4uy9A:20.7","4i41A-4uy9A:27.95"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"GLY A 151;VAL A 158;ALA A 169;LEU A 206;LEU A 218;GLY A 226;LEU A 275","None","0.63A","4ifgA-4uy9A:24.4","4ifgA-4uy9A:24.24"],["4M93_B_ACTB304_0","S25-26 FAB (IGG1K) HEAVY CHAIN;S25-26 FAB (IGG1K) LIGHT CHAIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"GLY A 329;SER A 330;ARG A 393;PRO A 390","None","1.43A","4m93B-4uy9A:1.0;4m93C-4uy9A:0.0","4m93B-4uy9A:20.97;4m93C-4uy9A:20.77"],["4O0S_A_ADNA500_1","AURORA KINASE A","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"GLY A 151;VAL A 158;ALA A 169;LYS A 171;ASN A 273;LEU A 275;ASP A 294","None","0.85A","4o0sA-4uy9A:23.3","4o0sA-4uy9A:27.93"],["4O0U_A_ADNA501_1","AURORA KINASE A","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"VAL A 158;ALA A 169;LYS A 171;LEU A 275","None","0.77A","4o0uA-4uy9A:7.8","4o0uA-4uy9A:27.63"],["4OGR_A_ADNA401_1","CYCLIN-DEPENDENT KINASE 9","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"ILE A 150;GLY A 153;VAL A 158;ALA A 169;ASN A 273;LEU A 275;ASP A 294","None","0.62A","4ogrA-4uy9A:22.7","4ogrA-4uy9A:26.74"],["4OGR_E_ADNE401_1","CYCLIN-DEPENDENT KINASE 9","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"GLY A 151;ALA A 169;ASN A 273;LEU A 275;ASP A 294","None","0.86A","4ogrE-4uy9A:21.8","4ogrE-4uy9A:26.74"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",7,"ILE A 150;GLY A 153;VAL A 158;ALA A 169;ASN A 273;LEU A 275;ASP A 294","None","0.67A","4ogrI-4uy9A:22.5","4ogrI-4uy9A:26.74"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"ILE A 150;GLY A 151;VAL A 158;ALA A 169;MET A 220;GLY A 226","None","0.80A","4qmzA-4uy9A:23.9","4qmzA-4uy9A:29.67"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"ILE A 150;GLY A 151;VAL A 158;ALA A 169;MET A 220;LEU A 275","None","0.64A","4qmzA-4uy9A:23.9","4qmzA-4uy9A:29.67"],["4UXQ_A_0LIA1752_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"ILE A 204;ALA A 223;ARG A 267;ILE A 292","None","0.68A","4uxqA-4uy9A:26.6","4uxqA-4uy9A:31.78"],["4UXQ_A_0LIA1752_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"VAL A 158;ILE A 204;ALA A 223;ILE A 292","None","0.49A","4uxqA-4uy9A:26.6","4uxqA-4uy9A:31.78"],["4V01_B_0LIB1770_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"VAL A 158;LYS A 171;ILE A 204;ARG A 267;LEU A 275;ILE A 292","None","0.92A","4v01B-4uy9A:26.9","4v01B-4uy9A:31.54"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"VAL A 158;ALA A 169;ALA A 223;LEU A 256;HIS A 266;GLY A 296","None","0.72A","4v04A-4uy9A:26.7","4v04A-4uy9A:31.54"],["4V04_A_0LIA1772_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"ILE A 204;ARG A 267;LEU A 275;ILE A 292","None","0.67A","4v04A-4uy9A:26.7","4v04A-4uy9A:31.54"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ALA A 169;ALA A 223;LEU A 256;HIS A 266;GLY A 296","None","0.74A","4v04B-4uy9A:26.7","4v04B-4uy9A:31.54"],["4Y0R_A_PX9A201_0","BETA-LACTOGLOBULIN","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ILE A 249;LEU A 338;ILE A 274;ILE A 292;PHE A 396","None","0.86A","4y0rA-4uy9A:undetectable","4y0rA-4uy9A:21.54"],["5HES_A_032A401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"VAL A 158;ALA A 169;ILE A 204;ALA A 223;PHE A 295","None","0.53A","5hesA-4uy9A:32.8","5hesA-4uy9A:40.92"],["5HIE_C_P06C801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"GLY A 151;GLY A 153;VAL A 158;ALA A 169;LYS A 171;ASP A 294","None","0.98A","5hieC-4uy9A:27.6","5hieC-4uy9A:30.33"],["5JWA_H_ACTH612_0","NADH DEHYDROGENASE, PUTATIVE","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",3,"ARG A 393;PRO A 318;ASN A 364","None","1.06A","5jwaA-4uy9A:undetectable;5jwaH-4uy9A:undetectable","5jwaA-4uy9A:20.12;5jwaH-4uy9A:20.12"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ILE A 150;GLY A 151;VAL A 158;ALA A 169;ILE A 204","None","0.37A","5lw1B-4uy9A:14.3","5lw1B-4uy9A:14.34"],["5MVM_A_PFLA510_1","PROTON-GATED ION CHANNEL;PROTON-GATED ION CHANNEL","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"ILE A 203;ALA A 205;ILE A 204;GLU A 221;ILE A 289","None","1.13A","5mvmA-4uy9A:undetectable;5mvmE-4uy9A:undetectable","5mvmA-4uy9A:12.38;5mvmE-4uy9A:12.38"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"VAL A 158;ALA A 169;LYS A 171;LEU A 275;THR A 293;ASP A 294","None","1.25A","5yu9D-4uy9A:27.0","5yu9D-4uy9A:13.70"],["6CNJ_A_NCTA402_1","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4;NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"CYH A 210;CYH A 217;TRP A 163;LEU A 144","None","1.48A","6cnjA-4uy9A:0.0;6cnjB-4uy9A:1.1","6cnjA-4uy9A:13.44;6cnjB-4uy9A:14.84"],["6CNK_B_NCTB402_1","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-4;NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-2","4uy9","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",4,"CYH A 210;CYH A 217;TRP A 163;LEU A 144","None","1.48A","6cnkB-4uy9A:undetectable;6cnkC-4uy9A:undetectable","6cnkB-4uy9A:13.44;6cnkC-4uy9A:14.84"]]